HOLOGIC INC (HO1.DE) Fundamental Analysis & Valuation

FRA:HO1 • US4364401012

Current stock price

69.09 EUR
+0.67 (+0.98%)
Last:

This HO1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. HO1.DE Profitability Analysis

1.1 Basic Checks

  • In the past year HO1 was profitable.
HO1.DE Yearly Net Income VS EBIT VS OCF VS FCFHO1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B 2B

1.2 Ratios

Industry RankSector Rank
ROA 16.16%
ROE 30.25%
ROIC 18.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HO1.DE Yearly ROA, ROE, ROICHO1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 10 20 30 40

1.3 Margins

Industry RankSector Rank
OM 36.65%
PM (TTM) 28.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HO1.DE Yearly Profit, Operating, Gross MarginsHO1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60

4

2. HO1.DE Health Analysis

2.1 Basic Checks

  • HO1 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, HO1 has less shares outstanding
  • The debt/assets ratio for HO1 has been reduced compared to a year ago.
HO1.DE Yearly Shares OutstandingHO1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M
HO1.DE Yearly Total Debt VS Total AssetsHO1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 4.19 indicates that HO1 is not in any danger for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.57 indicates that HO1 is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 4.19
ROIC/WACC2
WACC9.06%
HO1.DE Yearly LT Debt VS Equity VS FCFHO1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 3.91 indicates that HO1 has no problem at all paying its short term obligations.
  • A Quick Ratio of 3.32 indicates that HO1 has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.32
HO1.DE Yearly Current Assets VS Current LiabilitesHO1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 1B 2B 3B

3

3. HO1.DE Growth Analysis

3.1 Past

  • The earnings per share for HO1 have decreased strongly by -23.16% in the last year.
  • The Earnings Per Share has been growing by 33.75% on average over the past years. This is a very strong growth
  • The Revenue has decreased by -7.71% in the past year.
  • HO1 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.74% yearly.
EPS 1Y (TTM)-23.16%
EPS 3Y55.3%
EPS 5Y33.75%
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-7.71%
Revenue growth 3Y20.51%
Revenue growth 5Y14.74%
Sales Q2Q%-14.17%

3.2 Future

  • Based on estimates for the next years, HO1 will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.46% on average per year.
  • HO1 is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.24% yearly.
EPS Next Y-29.23%
EPS Next 2Y-35.02%
EPS Next 3Y-21.49%
EPS Next 5Y-18.46%
Revenue Next Year-10.55%
Revenue Next 2Y-15.53%
Revenue Next 3Y-8.65%
Revenue Next 5Y-8.24%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HO1.DE Yearly Revenue VS EstimatesHO1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
HO1.DE Yearly EPS VS EstimatesHO1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

2

4. HO1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.12, the valuation of HO1 can be described as very reasonable.
  • HO1's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.17.
  • With a Price/Forward Earnings ratio of 19.41, HO1 is valued on the expensive side.
  • HO1's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.05.
Industry RankSector Rank
PE 10.12
Fwd PE 19.41
HO1.DE Price Earnings VS Forward Price EarningsHO1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.48
HO1.DE Per share dataHO1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • A cheap valuation may be justified as HO1's earnings are expected to decrease with -21.49% in the coming years.
PEG (NY)N/A
PEG (5Y)0.3
EPS Next 2Y-35.02%
EPS Next 3Y-21.49%

0

5. HO1.DE Dividend Analysis

5.1 Amount

  • HO1 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HO1.DE Fundamentals: All Metrics, Ratios and Statistics

HOLOGIC INC

FRA:HO1 (9/8/2022, 7:00:00 PM)

69.09

+0.67 (+0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.25B
Revenue(TTM)5.23B
Net Income(TTM)1.51B
Analysts75.65
Price Target79.63 (15.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.12
Fwd PE 19.41
P/S 3.29
P/FCF N/A
P/OCF N/A
P/B 3.44
P/tB N/A
EV/EBITDA 7.48
EPS(TTM)6.83
EY9.89%
EPS(NY)3.56
Fwd EY5.15%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.03
BVpS20.11
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.3
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 16.16%
ROE 30.25%
ROCE N/A
ROIC 18.15%
ROICexc N/A
ROICexgc 41.74%
OM 36.65%
PM (TTM) 28.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.32
Altman-Z 4.19
F-Score6
WACC9.06%
ROIC/WACC2
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.16%
EPS 3Y55.3%
EPS 5Y33.75%
EPS Q2Q%-28.57%
EPS Next Y-29.23%
EPS Next 2Y-35.02%
EPS Next 3Y-21.49%
EPS Next 5Y-18.46%
Revenue 1Y (TTM)-7.71%
Revenue growth 3Y20.51%
Revenue growth 5Y14.74%
Sales Q2Q%-14.17%
Revenue Next Year-10.55%
Revenue Next 2Y-15.53%
Revenue Next 3Y-8.65%
Revenue Next 5Y-8.24%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

HOLOGIC INC / HO1.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HOLOGIC INC?

ChartMill assigns a fundamental rating of 6 / 10 to HO1.DE.


What is the valuation status of HOLOGIC INC (HO1.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to HOLOGIC INC (HO1.DE). This can be considered as Fairly Valued.


What is the profitability of HO1 stock?

HOLOGIC INC (HO1.DE) has a profitability rating of 8 / 10.


Can you provide the financial health for HO1 stock?

The financial health rating of HOLOGIC INC (HO1.DE) is 7 / 10.


Can you provide the expected EPS growth for HO1 stock?

The Earnings per Share (EPS) of HOLOGIC INC (HO1.DE) is expected to decline by -29.23% in the next year.